Bortezomib improves adoptive carbonic anhydrase IX-specific chimeric antigen receptor-modified NK92 cell therapy in mouse models of human renal cell carcinoma.
- Resource Type
- Article
- Source
- Oncology Reports; Dec2018, Vol. 40 Issue 6, p3714-3724, 11p
- Subject
- Language
- ISSN
- 1021335X